For instance, PI3K inhibitors such as BKM120 have revealed decreased proliferation and increased apoptosis in not only tumor cell lines[55], and tumor xenograft models[55], but also cancer patients with PI3K activating mutations[55]. This evidence concerns the gene PIK3CA and cancer.